HLA class II disease associations in southern Africa (Q36379492)

13 August 2017

1 reference

title

HLA class II disease associations in southern Africa (English)

1 reference

13 August 2017

0 references

Lombard Z

1

1 reference

13 August 2017

Brune AE

2

1 reference

13 August 2017

Hoal EG

3

1 reference

13 August 2017

Babb C

4

1 reference

13 August 2017

Van Helden PD

5

1 reference

13 August 2017

Epplen JT

6

1 reference

13 August 2017

Bornman L

7

1 reference

13 August 2017

publication date

1 February 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

67

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

97-110

1 reference

Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Invited anniversary review: HLA associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Research and clinical aspects of immunology in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Histocompatibility (HL-A) Antigens, Lymphocytotoxic Antibodies and Tissue Antibodies in Patients with Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

The genetic susceptibility to type I (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA-A, B, C and DR antigens in young South African blacks with Type 1 (insulin-dependent) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA class I and II antigens in South African blacks with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HTLV-I associated myelopathy, a new clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Immunogenetics of HTLV-I/II and associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Muellerianosis of the urinary bladder, endocervicosis type: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA antigens in multiple sclerosis in coloured South Africans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Mycobacterium tuberculosis: here today, and here tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Human leukocyte antigens in tuberculosis and leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Associations of HLA class II alleles with pulmonary tuberculosis in Thais

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA and in vitro susceptibility to HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Common west African HLA antigens are associated with protection from severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Science, medicine, and the future: susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

Immunogenetics and genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00530.X

10.1111/J.1399-0039.2006.00530.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference